Scalable Synthesis of the Key Fexuprazan Intermediate and Investigation of a Reaction Mechanism
ACS Omega · 10.09.2024 · 9 (36) · 37942-37952
DOI: 10.1021/acsomega.4c04507 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 23.08.2024. Verfasst von Ting Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
- Key Laboratory of Intelligent Drug Design and New Drug Discovery of Liaoning Province, Shenyang Pharmaceutical University, Shenyang 110016, China.
ORCID-Profile: Yang Liu, Maosheng Cheng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, T., Hua, Y., Deng, F., Wen, R., Zhang, H., Li, C., Liu, Y., & Cheng, M. (2024). Scalable Synthesis of the Key Fexuprazan Intermediate and Investigation of a Reaction Mechanism. ACS Omega, 9(36), 37942-37952. https://doi.org/10.1021/acsomega.4c04507
Vancouver
Wang T, Hua Y, Deng F, Wen R, Zhang H, Li C, et al. Scalable Synthesis of the Key Fexuprazan Intermediate and Investigation of a Reaction Mechanism. ACS Omega. 2024;9(36):37942-37952. doi:10.1021/acsomega.4c04507
BibTeX
@article{Wang2024,
author = {Wang, Ting and Hua, Yueting and Deng, Fangbo and Wen, Rui and Zhang, Haoyu and Li, Chunshi and Liu, Yang and Cheng, Maosheng},
title = {Scalable Synthesis of the Key Fexuprazan Intermediate and Investigation of a Reaction Mechanism},
journal = {ACS Omega},
year = {2024},
volume = {9},
number = {36},
pages = {37942--37952},
doi = {10.1021/acsomega.4c04507}
}
EUVIMED